<-- Back to proposed bills
Prostate Cancer Screening
02 June 2026
Type
Written Ministerial Statement
Department
Department of Health and Social Care
TAGS
At a Glance
Issue Summary
The Minister is announcing the introduction of a targeted prostate cancer screening programme for men with a known BRCA2 gene variant and relevant family history.
Action Requested
The Government will roll out a targeted prostate cancer screening programme using an IT call and recall system starting in 2027, invest over £20 million to expand research and improve treatment, and update guidance for GPs and the public. Additionally, they are hosting a roundtable with local community organisations to boost engagement.
Key Facts
- The targeted prostate cancer screening programme will begin roll-out in 2027.
- Men aged 45 to 61 with a known BRCA2 gene variant and relevant family history will be offered PSA screening every two years.
- The Government is investing over £20 million, including up to an additional £18 million to the TRANSFORM trial and up to £2.8 million in focal therapy.
- Community level research for all eligible Black men between 45 and 74 years will be invited to participate in stage 2 of the TRANSFORM trial.
▸
Assessment & feedback
Summary accuracy